Chronic Non-Communicable Disease Risk Calculators - An Overview, Part II
Related Experiment Video
Updated: Nov 26, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Fabienne Juchli1, Martina Zangger2, Andrea Schueck3
1Department of General Internal Medicine, Muri Hospital, Muri, Switzerland.
Insights
This review identifies risk assessment tools for stroke, heart disease, type 2 diabetes, and dementia. These tools help physicians select appropriate methods for early detection and treatment of non-communicable diseases (NCDs).
Area of Science:
- Medical Science
- Public Health
- Preventive Medicine
Background:
- Non-communicable diseases (NCDs) are leading causes of mortality globally.
- Part I of this review covered risk assessment for breast cancer, lung cancer, colorectal cancer, and osteoporosis.
- Effective risk stratification is crucial for preventive healthcare strategies.
Purpose of the Study:
- To identify and compare risk assessment tools for stroke, ischaemic heart diseases, type 2 diabetes mellitus, and dementia.
- To provide physicians with an overview of available tools for estimating individual NCD risk.
- To support clinical decision-making for early detection and management of major NCDs.
Main Methods:
- Systematic review of existing risk assessment tools.
- Comparison of tools based on their variables and validation criteria.
- Development of overview tables for each targeted NCD.
Main Results:
- Identified various risk assessment tools for stroke, ischaemic heart diseases, type 2 diabetes mellitus, and dementia.
- Compared the characteristics and validation of these tools.
- Created comprehensive tables to aid in tool selection.
Conclusions:
- The developed overview tables facilitate the selection of appropriate risk assessment tools for individual patients.
- This guidance can improve early detection and treatment decisions for NCDs.
- Optimizing tool selection can preserve patient quality of life and minimize healthcare costs.
Abstract:
The aim of this review was to identify the different risk assessment tools that stratify the individual's risk of four of the eight leading causes of death: stroke, ischaemic heart diseases, type 2 diabetes mellitus, and dementia. It follows part I, which summarized the risk assessment tools for the other four leading causes of death (breast cancer, lung cancer, colorectal cancer and osteoporosis). As in part I, the different tools were compared by their variables and validation criteria and an overview table was designed for each illness. The tables facilitate the choice of the adequate risk assessment tool for the individual patient in order to estimate the risk of developing an NCD. This could guide treating physicians in the decision-making process about completing diagnostics for early detection and, if necessary, treatment, such that the patient's quality of life can be preserved and costs to the health care system are minimal.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Coronary Artery Disease I: Introduction
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Relative Risk
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Chronic Kidney Disease I: Introduction

